Daiichi Sankyo has committed Y100m ($1m) and Mitsubishi UFJ Capital will be investing as much as Y200m ($2m) with the Organization for Small & Medium Enterprises and Regional Innovation pledging Y450m ($4.5m).

Japan-based pharmaceutical company Daiichi Sankyo and Japan corporate investment unit Mitsubishi UFJ Capital have launched an open innovation business through the Organization for Small & Medium Enterprises and Regional Innovation (OiDE Fund Investment Limited Partnership). The fund will be operated by Mitsubishi UFJ Capital with combined commitments of Y750m ($7.5m).

Daiichi Sankyo has committed Y100m ($1m) and Mitsubishi UFJ Capital will be investing as much as Y200m ($2m) with the Organization for Small & Medium Enterprises and Regional Innovation pledging…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?